Jonathan Yen-Wen  Yu net worth and biography

Jonathan Yu Biography and Net Worth

Jonathan is the Chief Operating Officer and oversees corporate strategy, business development and commercial strategy at Disc Medicine. Previously, he was a co-founder of Qpex Biopharma and the Vice President of Corporate Strategy, Finance and Operations, where he led all business functions including the spin-out of the company’s core assets, its Series A financing and its partnerships. Before Qpex, Jonathan served in various leadership roles at The Medicines Company, most recently as Vice President of Strategic Planning and Corporate Development, where he was instrumental in the divestiture of commercial-stage infectious disease assets to Melinta Therapeutics and the acquisition and subsequent integration of Rempex Pharmaceuticals. Jonathan has also held a variety of roles at SR One, Acceleron Pharma and Johnson & Johnson, spanning commercial planning and assessment, business development and finance. He holds an MBA from the Wharton School of the University of Pennsylvania and an AB in Biochemical Sciences from Harvard College.

What is Jonathan Yen-Wen Yu's net worth?

The estimated net worth of Jonathan Yen-Wen Yu is at least $2.13 million as of February 18th, 2025. Yu owns 40,555 shares of Disc Medicine stock worth more than $2,125,488 as of March 14th. This net worth estimate does not reflect any other investments that Yu may own. Additionally, Yu receives a salary of $539,320.00 as COO at Disc Medicine. Learn More about Jonathan Yen-Wen Yu's net worth.

How old is Jonathan Yen-Wen Yu?

Yu is currently 43 years old. There are 7 older executives and no younger executives at Disc Medicine. The oldest executive at Disc Medicine is Dr. Donald William Nicholson Ph.D., Executive Chairman, who is 66 years old. Learn More on Jonathan Yen-Wen Yu's age.

What is Jonathan Yen-Wen Yu's salary?

As the COO of Disc Medicine, Inc., Yu earns $539,320.00 per year. There are 2 executives that earn more than Yu. The highest earning executive at Disc Medicine is Dr. John D. Quisel Esq., J.D., Ph.D., CEO, President & Director, who commands a salary of $903,460.00 per year. Learn More on Jonathan Yen-Wen Yu's salary.

How do I contact Jonathan Yen-Wen Yu?

The corporate mailing address for Yu and other Disc Medicine executives is 297 Boston Post Road #248, Wayland MA, 01778. Disc Medicine can also be reached via phone at 617-401-4400 and via email at ir@geminitherapeutics.com. Learn More on Jonathan Yen-Wen Yu's contact information.

Has Jonathan Yen-Wen Yu been buying or selling shares of Disc Medicine?

During the last quarter, Jonathan Yen-Wen Yu has sold $87,873.80 of Disc Medicine stock. Most recently, Jonathan Yen-Wen Yu sold 1,610 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $54.58, for a transaction totalling $87,873.80. Following the completion of the sale, the chief operating officer now directly owns 40,555 shares of the company's stock, valued at $2,213,491.90. Learn More on Jonathan Yen-Wen Yu's trading history.

Who are Disc Medicine's active insiders?

Disc Medicine's insider roster includes Mona Ashiya (Director), Kevin Bitterman (Director), Joanne Bryce (CFO), Jean Franchi (CFO), Rahul Khara (Insider), Brian Macdonald (Insider), John Quisel (CEO), William Savage (Insider), Pamela Stephenson (Insider), William White (Director), and Jonathan Yu (COO). Learn More on Disc Medicine's active insiders.

Are insiders buying or selling shares of Disc Medicine?

During the last year, insiders at the sold shares 19 times. They sold a total of 395,005 shares worth more than $22,156,241.87. The most recent insider tranaction occured on March, 12th when Director Mona Ashiya sold 83,182 shares worth more than $4,529,259.90. Insiders at Disc Medicine own 4.2% of the company. Learn More about insider trades at Disc Medicine.

Information on this page was last updated on 3/12/2025.

Jonathan Yen-Wen Yu Insider Trading History at Disc Medicine

See Full Table

Jonathan Yen-Wen Yu Buying and Selling Activity at Disc Medicine

This chart shows Jonathan Yen-Wen Yu's buying and selling at Disc Medicine by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$88ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$50k$0$50kTotal Insider BuyingTotal Insider Selling

Disc Medicine Company Overview

Disc Medicine logo
Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.
Read More

Today's Range

Now: $52.41
Low: $52.36
High: $54.84

50 Day Range

MA: $56.62
Low: $53.37
High: $63.82

2 Week Range

Now: $52.41
Low: $25.60
High: $68.86

Volume

263,058 shs

Average Volume

359,832 shs

Market Capitalization

$1.81 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.73